clarithromycin has been researched along with Conjunctival Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auw-Hädrich, C; Bogdan, C; Finke, J; Mittelviefhaus, H; Reinhard, T; Serr, A | 1 |
| Haas, K | 1 |
| Crocchiolo, R; Dognini, GP; Ferreri, AJ; Govi, S; Licata, G; Ponzoni, M; Resti, AG | 1 |
| Danilko, L; Haas, K; Schönherr, U; Tschurtschenthaler, G | 1 |
1 trial(s) available for clarithromycin and Conjunctival Neoplasms
| Article | Year |
|---|---|
Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Clarithromycin; Conjunctival Neoplasms; Eye Neoplasms; Feasibility Studies; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Treatment Outcome | 2010 |
3 other study(ies) available for clarithromycin and Conjunctival Neoplasms
| Article | Year |
|---|---|
[Clarithromycin for monotherapy of B-cell MALT lymphoma?].
Topics: Clarithromycin; Conjunctival Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone | 2013 |
[Reply].
Topics: Clarithromycin; Conjunctival Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone | 2013 |
[Clarithromycin therapy of a B cell MALT lymphoma].
Topics: Adult; Antineoplastic Agents; Clarithromycin; Conjunctival Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Pilot Projects; Protein Synthesis Inhibitors; Treatment Outcome | 2013 |